MedCare Investment Funds, Logo



James R. Leininger, MD

Dr. Leininger has been a founder and investor in more than 40 companies. In 1976 he founded Kinetic Concepts (KCI:NYSE) as a specialty hospital bed company and served as CEO and then Chairman for over 20 years (he is now Chairman Emeritus). KCI has grown to be a diversified equipment, device and biologics company focused on preventing and healing wounds of all types; it had 2009 revenues of approximately $2 billion. In 1991, Dr. Leininger formed a private venture investment firm known as MedCare Investment Funds through utilization of his private equity and management firm. He is also a co-founder of Renal Care Group along with Dr. Jacobson and the late Sam Brooks.

Dr. Leininger has founded and established numerous healthcare companies through or with his private equity team. Examples include companies in the healthcare services sector (an ambulatory services company partnering with physicians and providing dialysis and radiation oncology services; an outpatient imaging services and management company), the medical technology sector (a medical device company with two CE Marks-approved devices and one FDA-approved device; a company developing a device to treat glaucoma and presbyopia), the healthcare information technology sector (a physician practice software company focused on women’s health; an early stage healthcare informatics company creating electronic medical records for Regional Health Information Organizations (RHIOs), large healthcare systems, hospitals and multisite practices; a benefits management company utilizing proprietary software), and the pharmaceutical sector (a pre-revenue drug discovery and development company with two promising drugs in phase III clinical trials).

Back to Top


Harry R. Jacobson, MD

Dr. Jacobson is Chairman of MedCare Investment Funds and a founding partner of TriStar Technology Ventures.  He  is former Vice Chancellor for Health Affairs at Vanderbilt University and CEO of Vanderbilt University Medical Center (VUMC). During Dr. Jacobson’s 11+ years of tenure, VUMC revenues grew from $750 million to $2.5 billion while delivering superior care at substantially lower costs seen in similar hospitals, its Federally-funded (NIH) research program moved from 24th to the top 10 in the country, and it opened over $1 billion of newly constructed research and patient care facilities. As a result, VUMC was recognized as a “most-wired” hospital as well as a U.S. News and World Report honor-roll hospital, and, most recently, as a Fortune 100 top place to work.

During the course of his career, Dr. Jacobson has been a successful investor and entrepreneur, having founded or co-founded eight companies, including (i) Contact Software (the developer of Act!, the world’s leading contact management software), which was acquired by Symantec (SYMC: NASDAQ); (ii) Renal Care Group (RCG: NYSE), a leading dialysis service company, acquired by Fresenius Medical Care (FMS: NYSE); (iii) Ambulatory Services of America, a diversified outpatient ancillary services provider of dialysis and radiation oncology services; (iv) Cardiovascular Care Group, an integrated provider of cardiovascular services (and its predecessor Cardiovascular Services of America); (v) Quality Healthcare International, a manager/operator of international healthcare facilities in countries seeking 21st century health services for their citizens; (vi) digiChart, a healthcare information technology company focused on women’s health; (vii) Informatics Corporation of America, an early-stage healthcare informatics company creating electronic medical records for regional health information organizations, large healthcare systems, hospitals and multisite practices; and (viii) CeloNova Biosciences, a medical device company with 2 CE-approved and 1 FDA-approved products. Dr. Jacobson served on the boards of 3 New York Stock Exchange companies; Merck, Kinetic Concepts, and Renal Care Group.  Currently Dr. Jacobson serves on the Board of Directors of Ingram Industries, as well as on the Boards of several healthcare companies in the MedCare portfolio.  In 2002 he was named the Ernst and Young Southeast Entrepreneur of the Year and was recently ranked No. 35 on Modern Physician’s ranking of the 50 Most Powerful Physician Executives in Healthcare. Dr. Jacobson is also a past chair of the Nashville Health Care Council Board of Directors.

Dr. Jacobson has published over 100 research articles, reviews, and book chapters and co-edited the book, The Principles and Practice of Nephrology.

After earning an M.D. degree from the University of Illinois in 1972, Dr. Jacobson completed an internal medicine residency at Johns Hopkins Hospital, and specialty training in nephrology at the University of Texas Health Science Center in Dallas. Dr. Jacobson is Board certified in both Internal Medicine and Nephrology. He joined the Vanderbilt Medical School faculty in 1985 as Professor of Medicine and Director of the Division of Nephrology and in 1997, became Vice Chancellor for Health Affairs.

Back to Top


Thomas W. “Tim” Lyles, Jr

Mr. Lyles has managed an investment portfolio for over 20 years, including both public and large private companies. He also serves on numerous for-profit and non-profit Boards of Directors. Mr. Lyles’ primary responsibility is President of a private holding company, which oversees both strategic and operational issues for companies with Dr. Leininger. In 1991, Dr. Leininger formed a private venture investment firm known as MedCare Investment Funds, which Mr. Lyles is a co-founder of, and he has served as President since 2002. As a founding partner, Mr. Lyles was an active member of management in founding Renal Care Group along with Dr. Jacobson and the late Sam Brooks. Mr. Lyles, through his role as President of MedCare Investment Funds, has founded and established numerous healthcare companies. Examples include companies in the healthcare services sector (an ambulatory services company partnering with physicians and providing dialysis and radiation oncology services; an outpatient imaging services and management company), the medical technology sector (a medical device company with two CE Marks-approved devices and one FDA-approved device; a company developing a device to treat glaucoma and presbyopia), the healthcare information technology sector (a physician practice software company focused on women’s health; an early stage healthcare informatics company creating electronic medical records for Regional Health Information Organizations (RHIOs), large healthcare systems, hospitals and multisite practices; a benefits management company utilizing proprietary software), and the pharmaceutical sector (two pre-revenue drug discovery and development companies with one initiating Phase I clinical trial planning and a second with two promising drugs in phase III clinical trials).

Mr. Lyles has also helped found and build multiple high tech businesses primarily involving data transmission over cellular technology. From 1984 to 1989, Mr. Lyles was an attorney with the law firm of Haynes and Boone in Dallas, Texas. During 1986 and 1987, he taught Real Estate Financing at Southern Methodist University in Dallas. From 1983 to 1984, he was appointed a Briefing Attorney for the Chief Justice of the Supreme Court of Texas. In 1983, Mr. Lyles received his J.D., Cum Laude from SMU School of Law. Prior to attending law school, he was employed by KPMG Peat Marwick. Mr. Lyles earned an accounting degree from Texas A & M University, where he graduated Summa Cum Laude in 1979. In addition, Mr. Lyles is a Certified Public Accountant and has written material for the Texas State Bar and has been a speaker for the State Bar of Texas and the Dallas Bar.

Back to Top


Todd Callister

Mr. Callister has 15 years of operating, consulting and investing experience. After serving as Tax Fellow to Senator Orrin Hatch in Washington, D.C., he spent 11 years with CURA Capital Corporation, a national medical equipment leasing company (fka KCI Financial Services). He served as Controller, CFO and President of CURA and was involved in $150 million in public and private debt and commercial transactions. Mr. Callister consulted with Mission City Management, Inc. and MedCare Investment Funds for five years where he performed diligence, negotiated deals and documents and oversaw many of the companies in Dr. Leininger’s portfolio funds. He also provided financial and management consulting services through his own consultancy for four years. Mr. Callister received his MBA from Brigham Young University after being ranked second in his executive program. He speaks Mandarin Chinese and lived in Taiwan for two years.

Back to Top


John Doulis, MD

Dr. Doulis is former Assistant Vice Chancellor and Chief Operations Officer of the Informatics Center at Vanderbilt University.  In this role, he was the single point of focus for the Informatics Center’s efforts to provide the most effective informatics and information technology infrastructure to meet the needs of the diverse operating units that make up VUMC. The objective of the position was to be best of class in support of medical center operations through informatics and information technology infrastructure.

As Chief Information Officer of MedCare, Dr. Doulis is responsible for the development of the information technology investment strategy for the fund and increase the value of the portfolio companies utilizing 20 years of experience as a physician executive, scientist, and architect and manager of healthcare information systems. Dr. Doulis received his M.D. from Monash University, Melbourne, Australia and has an extensive publication and presentation record.

Back to Top